SCHEMBL516619

SCHEMBL516619

NS(=O)(=O)c1nc2ncccc2[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.56
PDE5A O76074 3/20 0.46
METAP1 P53582 2/20 0.46
METAP2 P50579 1/20 0.46
FGFR1 P11362 2/20 0.43
FLT1 P17948 2/20 0.43
AURKA O14965 5/20 0.42
HPSE Q9Y251 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
MAPK1 P28482 1/20 0.41
CA9 Q16790 1/20 0.41
TP53 P04637 1/20 0.41
KDM4E B2RXH2 1/20 0.40
CYP1A2 P05177 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL569578 0.83 NUDT1 (0.51) NUDT1PDE5AMETAP1METAP2AURKA
SCHEMBL10466026 0.75 NUDT1 (0.44) NUDT1PDE5AMETAP1METAP2AURKA
SCHEMBL29815201 0.73 L3MBTL1 (0.68) NUDT1METAP1METAP2CA2MAPK1
SCHEMBL830431 0.73 L3MBTL1 (0.68) NUDT1METAP1METAP2CA2MAPK1
SCHEMBL10466652 0.72 L3MBTL1 (0.49) NUDT1CA1CA2MAPK1CA9
SCHEMBL8354989 0.72 METAP2 (0.42) METAP1METAP2
SCHEMBL3997824 0.72 NUDT1 (0.75) NUDT1PDE5AMETAP1METAP2FGFR1
SCHEMBL3998276 0.72 NUDT1 (0.75) NUDT1PDE5AMETAP1METAP2FGFR1
SCHEMBL323981 0.72 NUDT1 (0.60) NUDT1PDE5AMETAP1METAP2FGFR1
SCHEMBL42319 0.72 NUDT1 (1.00) NUDT1PDE5AMETAP1METAP2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115322190-B Pyridoimidazole acyl sulfonamide derivative, and preparation method and application thereof 山东大学 2023-09-22 CN disclosed
US-20180273534-A1 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-09-27 US disclosed
US-10059706-B2 Pyrazolopyridine sulfonamides as nematicides BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2018-08-28 US disclosed
CN-105578885-B Imidazo thiophene (two) azoles sulfonamide as nematicide 拜耳作物科学股份公司 2018-06-26 CN disclosed
CN-106661022-B Pyrazolopyridine sulfonamides as nematicides 拜耳作物科学股份公司 2018-05-04 CN disclosed
EP-3139743-B1 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES BAYER CROPSCIENCE AG (DE) 2018-03-14 EP disclosed
US-9789118-B2 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof NOVARTIS AG (CH) 2017-10-17 US disclosed
EP-3024330-B1 IMIDAZOTHIA(DIA)ZOLE SULFONAMIDES AS NEMATICIDES BAYER CROPSCIENCE AG (DE) 2017-08-30 EP disclosed
CN-106661022-A Pyrazolopyridine sulfonamides as nematicides 拜耳作物科学股份公司 2017-05-10 CN disclosed
US-20170088548-A1 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-03-30 US disclosed
US-8697739-B2 Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof NOVARTIS AG (CH) 2014-04-15 US disclosed
US-20120028969-A1 BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF NOVARTIS AG (CH) 2012-02-02 US disclosed
CN-101014596-A Imidazoquinolinylsulfonamides, imidazopyridinylsulfonamides, and imidazo-1, 5-naphthyridinylsulfonamides 3M INNOVATIVE PROPERTIES CO (US) 2007-08-08 CN disclosed
US-4943570-A GASTROINTESTINAL DISORDERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1990-07-24 US disclosed
US-4943570-A GASTROINTESTINAL DISORDERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1990-07-24 US disclosed
US-4943570-A GASTROINTESTINAL DISORDERS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1990-07-24 US disclosed
US-4933338-A ANTIULCER AGENTS, ANTISECRETORY AGENTS, TREATMENT OF GASTROINTESTINAL DISORDERS; CHEMICAL INTERMEDIATES LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1990-06-12 US disclosed
US-4933338-A ANTIULCER AGENTS, ANTISECRETORY AGENTS, TREATMENT OF GASTROINTESTINAL DISORDERS; CHEMICAL INTERMEDIATES LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1990-06-12 US disclosed
EP-0246126-A1 Benzimidazoles and imidazopyridine sulfone amides, process for their preparation and their use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1987-11-19 EP disclosed
EP-0246126-A1 Benzimidazoles and imidazopyridine sulfone amides, process for their preparation and their use as medicaments LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 1987-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088548-A1 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES NISCH, CATSPER1, KCNH1 NUDT1 1043/4885PDE5A 1117/4885METAP1 1385/4885
US-20180273534-A1 PYRAZOLOPYRIDINE SULFONAMIDES AS NEMATICIDES NISCH, CATSPER1, KCNH1 NUDT1 1043/4885PDE5A 1117/4885METAP1 1385/4885
US-20120028969-A1 BICYCLIC ACETYL-COA CARBOXYLASE INHIBITORS AND USES THEREOF ACACA, ACACB, COASY NUDT1 2147/4885PDE5A 2063/4885METAP1 1641/4885
US-10059706-B2 Pyrazolopyridine sulfonamides as nematicides NISCH, CATSPER1, KCNH1 NUDT1 1043/4885PDE5A 1117/4885METAP1 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.